Latest news for Aldebaran Resources (OTC:ADBRF) Stock

Aldebaran Resources Inc is a Canadian mineral exploration company. Aldebaran has the right to earn from the Altar copper-gold project in San Juan Province, Argentina from Sibanye Stillwater. Altar hosts a large porphyry copper-gold system with mineralization currently defined in three distinct zones and forms part of a cluster of porphyry copper deposits which includes Los Pelambres (Antofagasta Minerals), El Pachon (Glencore), and Los Azules (McEwen Mining). The firm is focused on the Altar project with a view to discovering new zones with higher-grade mineralization.

ALDEBARAN RESOURCES INC by Aldebaran Resources Inc.

Aldebaran Resources Inc

The Trump campaign reportedly worked with Elon Musk&#8216;s social media platform, X, to halt the dissemination of hacked campaign materials on the former president's <a href="https://www.benzinga.com/topic/jd-vance">running mate</a>, Sen. JD Vance (R-Ohio).
What Happened: These materials, allegedly acquired through an Iranian hack, were shared by independent journalist Ken Klippenstein, leading to the suspension of his account and the blocking of links to his Substack.
According <a href="https://www.nytimes.com/2024/10/11/us/politics/elon-musk-donald-trump-pennsylvania.html">to</a> The New York Times, Klippenstein&#8217;s actions were deemed a violation of X&#8217;s rules, as he posted &#8220;unredacted private personal information,&#8221; including sensitive data about Vance.
This collaboration between X and the Trump campaign has sparked concerns among lawmakers, with Rep. Dan Goldman (D-N.Y.) questioning the potential for hearings on the matter.
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
The House Judiciary&#8217;s weaponization subcommittee has previously investigated alleged censorship of conservative speech by the Biden administration.
The FBI confirmed that the hack, targeting the Trump campaign, was orchestrated by Iran.
See Also: <a href="https://www.benzinga.com/news/24/10/41284847/tesla-reveals-two-seater-cybercab-that-drives-itself?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Tesla Unveils 2-Seater Cybercab That Drives Itself, Price Expected To Be Under $30K</a>
Why It Matters: The suspension of Klippenstein&#8217;s account on X has led to <a href="https://www.benzinga.com/news/24/09/41078347/elon-musk-gets-labelled-as-an-outspoken-trump-supporter-after-journalist-gets-banned-on-x-for-publis">accusations</a> against Musk of being an &#8220;outspoken&#8221; Trump supporter.
This incident follows warnings from the FBI and other intelligence agencies about potential Iranian attempts to influence the U.S. election, as reported on <a href="https://www.benzinga.com/news/24/09/41082565/threads-cuts-access-to-controversial-leaked-documents-on-jd-vance">Threads</a>, which also restricted access to the leaked documents.
Earlier, U.S. intelligence agencies revealed that Iran tried to share hacked Trump campaign data with President Biden&#8217;s team, though the FBI found no evidence of a response from Biden&#8217;s campaign, as detailed in a <a href="https://www.benzinga.com/news/24/09/40933501/us-intel-agencies-reveal-iran-tried-to-share-hacked-trump-campaign-data-with-team-biden-fbi-says-no">joint statement</a> by the FBI, ODNI, and CISA.
This situation <a href="https://www.benzinga.com/news/22/11/29850290/elon-musk-says-making-internal-twitter-conversations-on-hunter-biden-laptop-story-public-necessary-t">echoes past controversies</a>, such as Musk&#8217;s decision to make internal Twitter conversations public regarding the censorship of the New York Post&#8217;s story on Hunter Biden&#8217;s laptop, which he deemed &#8220;necessary to restore public trust."
Check out more of Benzinga's Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/entertainment/24/10/41269219/michael-jordan-buys-a-new-private-jet-that-is-also-owned-by-tech-billionaires-elon-musk-and?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Michael Jordan Buys A New Private Jet That Is Also Owned By Tech Billionaires Elon Musk And Jeff Bezos</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

News

Social Media

Politics

Tech

Elon Musk Collaborated With Trump Campaign To Block Hacked JD Vance Material Off X: Report

EV giant Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) <a href="https://www.benzinga.com/news/24/10/41284847/tesla-reveals-two-seater-cybercab-that-drives-itself">unveiled the Robovan</a> on Thursday &#8211; a vehicle designed for autonomous driving with no steering wheel or pedals but astoundingly low ground clearance and an angular design.
What Happened: The Robovan, Musk said on Friday, was inspired by Art Deco trains designed during the early 20th century. It can transport up to 20 people or cargo, the company CEO said during its unveiling.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Art Deco trains
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1844614396905185646?ref_src=twsrc%5Etfw">October 11, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Like an art deco train, the vehicle has no side mirrors and immediately looks like it lacks wheels owing to its extremely low ground clearance. The vehicle was meant to feel like a spaceship on the inside, Musk said, while adding that those traveling in the vehicle would have visibility in all directions. 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Meant to feel like a spaceship
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1844669426169520277?ref_src=twsrc%5Etfw">October 11, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Musk said that the &#8220;unusually low&#8221; ground clearance was achieved by having an automatic load-leveling suspension that raises ride height and lowers it based on road conditions.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The unusually low ground clearance is achieved by having an automatic load-leveling suspension that raises or lowers, based on smooth or bumpy road conditions
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1844669182354358308?ref_src=twsrc%5Etfw">October 11, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Why It Matters: Though Musk introduced the vehicle as a Robovan at Tesla&#8217;s event held near Los Angeles on Thursday, he has since then also referred to it as the Robobus. 
The company <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41286875/tesla-analysts-rave-over-cybercabs-design-cost-advantage-but-production-timeline-sp">did not provide a price point</a> for the vehicle or even when it will enter production. However, the unusual design has raised intrigue among Tesla enthusiasts. 
Tesla also unveiled a two-seater vehicle with butterfly wings that open upwards dedicated to autonomous driving on Thursday nicknamed the Cybercab. The Cybercab, Musk said on Thursday, will be priced below $30,000 and enter production in 2026. However, the CEO is known for providing over-ambitious timelines for his company&#8217;s products and achievements. 
Check out more of Benzinga&#8217;s Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link</a>.
Read More:
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41286158/gm-unit-launches-home-battery-powerbank-to-rival-teslas-powerwall" target="_blank" rel="noreferrer noopener">GM Unit Launches Home Battery PowerBank To Rival Tesla's Powerwall</a></li>
</ul>
Photo courtesy: Tesla

TSLA

Elon Musk Says Robovan's Angular Design Inspired By Art Deco Trains, 'Unusually Low' Ground Clearance Enabled By Automatic Load-Leveling Suspension

Tim Cook-led Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) is facing accusations from the U.S. National Labor Relations Board, or NLRB, for allegedly restricting its employees&#8217; use of social media and Slack for advocating improved working conditions.
What Happened: The NLRB lodged a complaint against Apple on Thursday, alleging that the tech behemoth has imposed unlawful work rules related to the use of Slack.
The complaint also said that Apple terminated an employee for advocating workplace changes on the platform and created an impression of surveillance over employees&#8217; social media activities, reported Reuters.
In its defense, Apple denied any wrongdoing and reaffirmed its commitment to fostering a positive and inclusive workplace. The company stated, &#8220;We&nbsp;strongly disagree with these claims&nbsp;and will continue to share&nbsp;the facts at the hearing.&#8221;
See Also:&nbsp;<a href="https://www.benzinga.com/news/24/10/41285255/tesla-pulls-an-apple-drops-the-charging-port-before-cupertino-could-remove-it-from-the-iphone?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Tesla Pulls An Apple, Drops The Charging Port Before Cupertino Could Remove It From The iPhone</a>
The complaint stemmed from a claim filed&nbsp;nearly three years ago by&nbsp;Janneke Parrish, who alleges Apple terminated her in 2021 for her&nbsp;role in employee activism.
Parrish&nbsp;used Slack and social media&nbsp;to advocate for permanent remote&nbsp;work, distribute a pay equity&nbsp;survey, and criticize the company.
If Apple does not reach a settlement&nbsp;with the NLRB, an administrative&nbsp;judge will conduct&nbsp;an initial hearing in the&nbsp;case in February.
The judge&#8217;s&nbsp;decision can be reviewed by&nbsp;the five-member labor board, and their&nbsp;rulings can be appealed in federal court.
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
Why It Matters: This marks the second complaint the NLRB has filed against Apple this month.
The earlier one accused the company of mandating <a href="https://www.benzinga.com/markets/equities/24/10/41136199/apple-accused-of-violating-federal-law-over-alleged-illegal-employee-agreements-nlrb-hearing-set">employees&nbsp;to sign illegal confidentiality</a>, nondisclosure,&nbsp;and noncompete agreements, and of enforcing&nbsp;overly broad misconduct and social&nbsp;media policies.
This is not the first time Apple has faced scrutiny from the NLRB. Last November, the federal labor board accused <a href="https://www.benzinga.com/markets/equities/23/11/35911746/labor-board-accuses-apple-of-anti-union-practices-report" target="_blank" rel="noopener">Apple of not extending a benefits</a> increase to unionized retail employees.
Cupertino has also faced <a href="https://www.benzinga.com/news/24/04/38193281/apple-faces-increased-union-efforts-from-new-jersey-store-will-previous-attempts-in-maryland-oklahom">increased unionization efforts</a> at its retail stores, which could potentially impact the company&#8217;s stock and shareholder sentiment.
Check out more of Benzinga's Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41284533/nvidias-blackwell-chip-faces-amds-mi350-challenge-in-2025-ceo-lisa-su-says-beginning-not-the-end-of?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Nvidia&#8217;s Blackwell Chip Faces AMD&#8217;s MI350 Challenge In 2025: CEO Lisa Su Says, &#8216;Beginning, Not The End Of The AI Race&#8217;</a></li>
</ul>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Media

AAPL

Tim Cook-Led Apple Accused By NLRB Of Restricting Employee Advocacy On Social Media: 2nd Complaint Against iPhone-maker This Month

Boeing (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) has revealed plans to cut its workforce by about 10%, reportedly equating to approximately 17,000 jobs.
What Happened: The layoffs will unfold over the next few months, affecting executives, managers, and other employees. Kelly Ortberg, Boeing&#8217;s president and CEO, communicated <a href="https://boeing.mediaroom.com/2024-10-11-Boeing-CEO-Message-to-Employees-on-Positioning-for-the-Future">this</a> decision to staff via email. According to a Reuters report, these layoffs will impact nearly 17,000 jobs.
The company has been grappling with significant challenges this year, including the grounding of Boeing 737 Max planes in January following a mid-flight incident.
In July, <a href="https://www.benzinga.com/news/24/07/39658887/boeing-strikes-plea-deal-with-doj-for-defrauding-us-regulator-over-737-max-safety-victims-lawyer-cal">Boeing accepted a guilty plea</a> over crashes involving the 737 Max in 2018 and 2019, which resulted in over 300 fatalities.
Additionally, Boeing&#8217;s Starliner spacecraft, which transported NASA astronauts to the International Space Station in June, <a href="https://www.benzinga.com/news/24/09/40758526/boeing-starliner-returns-to-earth-without-sunita-williams-and-butch-wilmore-lands-in-new-mexico-afte">returned without astronauts</a> in September due to technical issues.
See Also: <a href="https://www.benzinga.com/news/24/10/41270224/trump-vs-harris-new-poll-shows-pennsylvania-may-flip-as-vice-presidents-support-among-this-key-group?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Trump Vs. Harris: New Poll Shows Pennsylvania May Flip As Vice President&#8217;s Support Among This Key Group Deteriorates</a>
Nearly 33,000 Boeing factory workers <a href="https://www.benzinga.com/news/24/09/40853982/boeings-stock-falls-as-33-000-aircraft-assembly-workers-strike">have been on strike</a> since mid-September, further complicating the company&#8217;s situation. Ortberg emphasized the necessity of these layoffs to align with Boeing&#8217;s financial reality and future recovery plans.
The delivery of the first 777X airplane is now postponed to 2026, as stated in Ortberg&#8217;s memo.
Why It Matters: The layoffs come amid a tumultuous period for Boeing, marked by ongoing labor strikes and safety concerns.
The strike, which began on Sept. 13, has significantly disrupted production, leading to a <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41257193/boeings-october-deliveries-expected-to-plummet-amid-strike-challenges-analyst">projected drop in October deliveries</a>. Despite attempts to negotiate with the union, no agreement has been reached, and Boeing&#8217;s credit rating has been placed under negative watch by S&amp;P Global Ratings.
Adding to the challenges, the <a href="https://www.benzinga.com/markets/equities/24/10/41236652/boeing-hit-with-737-safety-alert-issues-deliveries-warning-as-strike-continues">Federal Aviation Administration</a> (FAA) recently issued a safety alert regarding the Boeing 737&#8217;s rudder system, further complicating the company&#8217;s situation.
The decision to cut health care benefits for 33,000 striking workers has also sparked criticism from the <a href="https://www.benzinga.com/news/24/10/41170226/boeing-workers-union-says-decision-to-cut-health-care-for-33-000-is-unnecessary-and-cruel">International Association of Machinists and Aerospace Workers</a>, adding to the tension.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41195209/elon-musk-says-humanity-will-never-reach-mars-unless-trump-wins-this-is-existential">Elon Musk Says &#8216;Humanity Will Never Reach Mars&#8217; Unless Trump Wins: &#8216;This Is Existential&#8217;</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Equities

Markets

Boeing Announces 10% Workforce Reduction Amidst Ongoing Struggles, Impacting Nearly 17K Employees

On Friday, at a rally in Aurora, Colorado, former President&nbsp;Donald Trump&nbsp;escalated his <a href="https://www.benzinga.com/markets/cannabis/24/09/41080016/trump-bashes-harris-border-visit-immigration-policy-worst-crisis-in-history-of-world-its-an-inva">anti-immigration rhetoric</a>, suggesting the&nbsp;&#8220;death penalty&#8221; for migrants who&nbsp;murder U.S. citizens.
What Happened: The Republican presidential candidate&nbsp;depicted migrants as dangerous criminals and proposed a nationwide &#8220;Operation Aurora&#8221; to target Venezuelan gang members if he wins the upcoming election, reported Reuters.
This proposal is part of his intensified anti-immigration stance in the final weeks leading up to the Nov. 5 election.
Trump said, &#8220;I&#8217;m hereby&nbsp;calling for the death penalty&nbsp;for any migrant that kills&nbsp;an American citizen or a&nbsp;law enforcement officer,&#8221; to&nbsp;a large crowd of supporters.
See Also:&nbsp;<a href="https://www.benzinga.com/news/24/10/41270224/trump-vs-harris-new-poll-shows-pennsylvania-may-flip-as-vice-presidents-support-among-this-key-group?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Trump Vs. Harris: New Poll Shows Pennsylvania May Flip As Vice President&#8217;s Support Among This Key Group Deteriorates</a>
This proposal expands on his previous suggestions to broaden&nbsp;the death penalty for other&nbsp;offenders, including those convicted of sex trafficking.
However, nearly&nbsp;half of U.S. states ban&nbsp;the death penalty, and its federal use is rare. Any&nbsp;expansion of eligible crimes would&nbsp;necessitate&nbsp;an act of the U.S.&nbsp;Congress, the report noted.
He also pledged&nbsp;to focus enforcement on Aurora&nbsp;if reelected, despite Aurora Mayor Mike Coffman stating that concerns&nbsp;about Venezuelan gang activity have&nbsp;been &#8220;grossly exaggerated.&#8221;
Why It Matters: Trump has previously made <a href="https://www.benzinga.com/markets/equities/24/10/41196721/trumps-dark-rhetoric-migrants-portrayed-as-criminals-amid-election-heat">unfounded claims that migrants</a> crossing the U.S. border were responsible for widespread violence.
His focus on &#8220;migrant crime&#8221; is a key feature of his third presidential run, despite studies showing&nbsp;immigrants do not commit crimes&nbsp;at a higher rate than&nbsp;native-born Americans.
Trump&#8217;s focus on immigration was also <a href="https://www.benzinga.com/markets/cannabis/24/09/40820699/trump-stuck-in-southern-border-and-immigration-loop-during-harris-debate-theyre-destroying-our-c">evident during a presidential debate</a> with Democratic nominee Kamala Harris, where he blamed illegal immigrants for drugs and murders.
The former president and his running mate Sen.&nbsp;JD Vance&nbsp;(R-Ohio.) have used the immigration issue as a <a href="https://www.benzinga.com/markets/cannabis/24/10/41299527/kamala-harris-defends-immigration-policy-at-latino-town-hall-criticizes-trumps-border-stance">cornerstone of their campaign speeches</a>, blaming undocumented immigrants for a rise in drug trafficking.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/10/41270606/kamala-harris-advises-on-howard-stern-show-dont-get-stoned-before-visiting-the-sphere-in-las-veg?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Kamala Harris Advises On Howard Stern Show: Don&#8217;t Get Stoned Before Visiting The Sphere In Las Vegas</a></li>
</ul>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Trump Steps Up Anti-Immigrant Rhetoric, Proposes Nationwide Plan To Target Venezuelan Gang Members

A federal judge has struck down parts of New Jersey&#8217;s <a href="https://www.benzinga.com/markets/cannabis/24/09/40845389/nj-governor-signs-bill-tightening-rules-on-hemp-industry-stakeholders-protest-big-alcohol-celebr">recently enacted hemp law</a>, ruling that certain provisions unlawfully restrict interstate commerce and conflict with federal regulations. The decision delivers a partial victory to <a href="https://www.benzinga.com/markets/cannabis/24/10/41217878/new-jersey-hemp-companies-file-lawsuit-over-strict-regulations-arguing-farm-bill-protects-them">hemp businesses that challenged the law</a>, though key restrictions remain in place.
<h3 class="wp-block-heading">NJ Hemp Law Violates Commerce Clause</h3>
U.S. District Court Judge Zahid N. Quraishi ruled on Wednesday that specific sections of the New Jersey Hemp Act Amendments (NJHAA) violate the dormant Commerce Clause and are preempted by the 2018 Farm Bill, which federally legalized hemp. <a href="https://newjerseymonitor.com/2024/10/10/judge-gives-partial-win-to-businesses-that-challenged-new-hemp-law/">According</a> to the New Jersey Monitor, the judge agreed with plaintiffs that the law&#8217;s definition of THC and its application discriminated against out-of-state hemp producers.
&#8220;The New Jersey Legislature cannot blatantly discriminate against out-of-state economic interests,&#8221; Judge Quraishi wrote in his <a href="https://newjerseymonitor.com/wp-content/uploads/2024/10/10-10-24-Loki-v.-Platkin-opinion.pdf">decision</a>.
<ul>
<li>Get Benzinga&#8217;s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter<a href="https://newsletteremail.benzinga.com/subscribe"> here</a>. If you&#8217;re serious about the business, you can&#8217;t afford to miss out.</li>
</ul>
The NJHAA, signed by Governor Phil Murphy (D) <a href="https://www.benzinga.com/markets/cannabis/24/09/40845389/nj-governor-signs-bill-tightening-rules-on-hemp-industry-stakeholders-protest-big-alcohol-celebr">last month</a>, aimed to regulate intoxicating hemp products amid concerns that minors were accessing them easily. The law banned sales of such products to individuals under 21 and required sellers to obtain licenses through the state&#8217;s Cannabis Regulatory Commission (CRC), <a href="https://www.nj.com/politics/2024/10/judge-tosses-parts-of-nj-law-that-limits-sale-of-intoxicating-hemp.html">noted</a> NJ.com.
<h3 class="wp-block-heading">Hemp Industry Celebrates Partial Legal Victory</h3>
While the judge upheld provisions banning sales to minors and the licensing requirement, he struck down parts that criminalized the sale or transport of federally compliant <a href="http://benzinga.com/topic/hemp">hemp products</a> from other states. The decision prevents enforcement of the law&#8217;s restrictions on out-of-state hemp, ensuring that products adhering to federal standards can be sold in New Jersey.
Adam Terry, CEO of Cantrip and one of the plaintiffs, expressed satisfaction with the ruling. &#8220;We are vindicated in the belief that an outright ban on hemp is not the path forward,&#8221; he said, <a href="https://www.forbes.com/sites/dariosabaghi/2024/10/11/businesses-partially-win-lawsuit-against-new-jerseys-hemp-ban-law/">according</a> to Forbes. &#8220;We must work together with lawmakers to develop sensible regulations.&#8221;
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/10/41299388/us-army-tightens-substance-abuse-regulations-banning-delta-8-thc-warns-against-poppy-seeds">US Army Tightens Substance Abuse Regulations, Banning Delta-8 THC, Warns Against Poppy Seeds</a>
Critics, including a coalition of hemp businesses, argued that these restrictions not only stifled competition but also infringed upon federal guidelines that allow for the free movement of hemp products across state lines. <a href="https://www.benzinga.com/markets/cannabis/24/10/41217878/new-jersey-hemp-companies-file-lawsuit-over-strict-regulations-arguing-farm-bill-protects-them">They warned the law would harm local businesses and consumers</a>, potentially forcing closures and job losses in the industry.&nbsp;
Moreover, concerns were also raised about the CRC&#8217;s ability to manage additional responsibilities without sufficient resources, as highlighted by NJ.com.
<h3 class="wp-block-heading">Bill Sponsor Calls For Hemp Law Adjustments</h3>
Senate Majority Leader M. Teresa Ruiz (D), a sponsor of the bill, acknowledged the need for legislative adjustments. &#8220;While I am pleased that the court order upheld the ban on selling intoxicating hemp products to minors, we must recognize that, without comprehensive regulation, these substances will continue to present a significant threat to the health and well-being of our communities,&#8221; <a href="https://www.nj.com/politics/2024/10/judge-tosses-parts-of-nj-law-that-limits-sale-of-intoxicating-hemp.html">said</a> Ruiz.
The judge&#8217;s ruling comes as the deadline for businesses to remove intoxicating hemp products from shelves approaches on October 12. Until the CRC establishes new regulations, these products cannot be sold in the state.
This decision adds to the ongoing national debate over the regulation of <a href="https://www.benzinga.com/markets/cannabis/24/01/36584043/real-weed-or-a-lab-high-delta-8-and-delta-9-thc-explained">psychoactive hemp products like delta-8 THC</a>, which remain in a legal gray area due to a lack of federal oversight.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/10/41297880/california-judge-rules-gov-newsoms-hemp-ban-stands-despite-industry-pushback">California Judge Rules Gov. Newsom&#8217;s Hemp Ban Stands Despite Industry Pushback</a></li>
</ul>

Cannabis

Government

Regulations

New Jersey Hemp Law Faces Setback As Federal Judge Blocks Out-of-State Product Ban

In a move that could mark the end of an era for legacy technology, Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) has reportedly ceased production of its 16-year-old SuperDrive.
What Happened: The SuperDrive, an external CD/DVD drive,&nbsp;is now listed as sold&nbsp;out or unavailable in all&nbsp;countries on Apple&#8217;s online store, <a href="https://www.macrumors.com/2024/10/11/apple-quietly-discontinues-16-year-old-accessory/">reported</a> MacRumors.
The accessory, which was launched in 2008&nbsp;alongside the original MacBook Air,&nbsp;has not been restocked, suggesting its discontinuation.
See Also:&nbsp;<a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41257775/uber-well-positioned-despite-tesla-robotaxi-threat-analyst-says?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Uber &#8216;Well Positioned&#8217; Despite Tesla Robotaxi Threat, Analyst Says</a>
The SuperDrive, despite its outdated USB-A cable, was one of Apple&#8217;s longest-sold products. However, with the CD/DVD drive market becoming increasingly niche, Apple&#8217;s decision to stop selling the SuperDrive is not unexpected.
Customers requiring CD/DVD drives have other alternatives that do not necessitate&nbsp;a USB-C adapter for use&nbsp;with modern Macs.
The term SuperDrive was first&nbsp;coined&nbsp;by Apple in 1988 with&nbsp;the launch&nbsp;of its 1.44 MB 3.5-inch&nbsp;floppy drive.
The concept underwent significant evolution with the introduction of optical media in 2001, and by&nbsp;the mid-2000s, the SuperDrive was available as an option in almost all Mac models.
Apple did not immediately respond to <a href="https://pro.benzinga.com/dashboard">Benzinga&#8217;s</a> request for comments.
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
Why It Matters: Over the years, Apple has phased out several key products and features, marking a shift in its product strategy.
The iPhone 13 mini, known for its compact 5.4-inch display, was discontinued in September 2024 due to low sales.
The 13-inch MacBook Pro with the Touch Bar, a once-innovative feature, was discontinued in late 2023 as Apple returned to traditional function keys.
The MagSafe Battery Pack and MagSafe Duo Charger, launched in 2021 and 2020 respectively, were also phased out following the transition to USB-C ports.
Apple has also replaced its leather accessories with eco-friendly FineWoven fabric but had to <a href="https://www.benzinga.com/news/24/09/40809459/apple-quietly-phases-out-categorically-terrible-finewoven-iphone-cases-report">phase them out too</a> due to some controversies. Other <a href="https://www.benzinga.com/news/23/11/35556821/apple-silent-bids-farewell-to-its-5month-siri-only-apple-music-voice-plan">notable discontinuations include</a> the iTunes Movie Trailers app and the Apple Music Voice Plan.
Check out more of Benzinga&#8217;s Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/10/41298806/wall-street-marks-new-record-highs-on-strong-start-to-earnings-season-investors-downplay-inflation-?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Wall Street Marks New Record Highs On Strong Start To Earnings Season, Investors Downplay Inflation Surge, Tesla Disappoints: This Week In The Market</a></li>
</ul>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

End Of An Era? Apple's 16-year-Old Accessory Is Out Of Stock Worldwide

North Carolina Gov. Roy Cooper (D) has refuted statements by former President&nbsp;Donald Trump&nbsp;regarding the distribution of disaster aid in the <a href="https://www.benzinga.com/markets/equities/24/10/41276280/hurricane-milton-closes-multiple-florida-airports-over-3-000-flights-canceled-and-delayed-10-air">aftermath of Hurricane Milton</a>.
What Happened: On Friday, Cooper took to X, formerly Twitter, and labeled Trump&#8217;s allegations as a &#8220;blatant falsehood.&#8221;
Trump accused Cooper&#8217;s administration of blocking aid and resources from reaching North Carolina to assist in recovery efforts post-Hurricane Milton.
The governor dismissed these accusations, asserting that his administration is working diligently with all stakeholders to provide necessary aid to those affected. &#8220;This is a flat out lie. We're working with all partners around the clock to get help to people.&#8221;
See Also:&nbsp;<a href="https://www.benzinga.com/news/24/10/41242570/trump-jr-says-his-dad-has-been-proven-right-again-after-fbi-foils-afghan-nationals-election-day-terr?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Trump Jr. Says His Dad &#8216;Has Been Proven Right Again&#8217; After FBI Foils Afghan National&#8217;s Election Day Terror Plot</a>
He went on to add that the Republican presidential nominee&#8217;s misleading statements have adversely affected&nbsp;the morale of first responders&nbsp;and victims, facilitated scams,&nbsp;and put government and rescue&nbsp;workers at risk.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">This is a flat out lie. We're working with all partners around the clock to get help to people. Trump's lies and conspiracy theories have hurt the morale of first responders and people who lost everything, helped scam artists and put government and rescue workers in danger. &#8211; RC <a href="https://t.co/QySXueCTOD">pic.twitter.com/QySXueCTOD</a>
&mdash; Governor Roy Cooper (@NC_Governor) <a href="https://twitter.com/NC_Governor/status/1844813387764830351?ref_src=twsrc%5Etfw">October 11, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Why It Matters: Previously, President&nbsp;Joe Biden&nbsp;called Trump&#8217;s allegations about Hurricane Milton &#8220;un-American.&#8221; FEMA has also launched a &#8220;rumor response&#8221; site to counter false claims related to disaster aid.
Trump previously took credit for the deployment of Elon Musk-led Starlink satellites to aid communication restoration in affected areas.
However, FEMA contradicted this statement, stating that the <a href="https://www.benzinga.com/news/24/10/41110218/trump-says-he-spoke-with-elon-musk-for-starlink-deployment-to-aid-hurricane-helene-affected-areas-bu">decision was already in place before Trump's</a> involvement.
Following this, Trump and other Republicans accused the <a href="https://www.benzinga.com/news/24/10/41195085/white-house-counters-gop-accusations-of-fema-funds-misuse-denies-disaster-relief-funding-was-used-fo">White House of misusing FEMA funds</a> for migrant housing, but the White House refuted this saying, &#8220;No disaster relief funding at all was used to support migrants housing and services. None. At. All.&#8221;
Meanwhile, the situation has worsened with Hurricane Milton, which left a trail of destruction in its wake. At least 16 people have lost their lives due to the storm, <a href="https://www.tampabay.com/hurricane/2024/10/10/miltons-wake-tampa-bay-picks-up-pieces-again/">according</a> to the Tampa Bay Times, and with recovery efforts still underway, that number could increase.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41223153/after-prisoner-swap-with-us-russia-sentences-72-years-old-american-man-for-alleged-mercenary-activit?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">After Prisoner Swap With US, Russia Sentences 72 Years Old American Man For Alleged &#8216;Mercenary&#8217; Activities With Ukraine</a></li>
</ul>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Photo courtesy: Flickr

North Carolina Governor Slams Trump's 'Flat Out Lie' About Disaster Aid: 'Lies And Conspiracy Theories Have Hurt The Morale Of First Responders'

PIXY

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending

Ameriprise Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMP#NYSE">AMP</a>) has outperformed the market over the past 15 years by 7.37% on an annualized basis producing an average annual return of 19.1%. Currently, Ameriprise Finl has a market capitalization of $49.45 billion. 
Buying $1000 In AMP: If an investor had bought $1000 of AMP stock 15 years ago, it would be worth $13,919.67 today based on a price of $502.50 for AMP at the time of writing.
<h3>Ameriprise Finl's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1728682223_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

Here's How Much You Would Have Made Owning Ameriprise Finl Stock In The Last 15 Years

Pure Storage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSTG#NYSE">PSTG</a>) has outperformed the market over the past 5 years by 10.53% on an annualized basis producing an average annual return of 24.69%. Currently, Pure Storage has a market capitalization of $17.43 billion. 
Buying $100 In PSTG: If an investor had bought $100 of PSTG stock 5 years ago, it would be worth $305.05 today based on a price of $53.20 for PSTG at the time of writing.
<h3>Pure Storage's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1728682218_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

PSTG

$100 Invested In This Stock 5 Years Ago Would Be Worth $300 Today

ZPTAW

Trading Halt: Halt status updated at 5:30:00 PM ET: Quotation Resumption: News and Resumption Times

ZPTA

Trading Halt: Halt status updated at 5:25:00 PM ET: Quotation Resumption: News and Resumption Times

JP Morgan Chase &amp; Co. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/jpm#NYSE">JPM</a>) and Wells Fargo &amp; Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wfc#NYSE">WFC</a>) ended the week by reporting their quarterly results, kicking off the third quarter earnings season.&nbsp;Bank of America Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bac#NYSE">BAC</a>) is due to report its latest financial results on Tuesday, with The Goldman Sachs Group (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gs#NYSE">GS</a>), Citigroup Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/c#NYSE">C</a>) and Morgan Stanley(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ms#NYSE">MS</a>)&nbsp;due to also report next week.
<h3>JP Morgan Reported A&nbsp;Better-Than-Expected Interest Income&nbsp;</h3>
During the quarter ended in September, JP Morgan reported&nbsp;revenues rose 6% YoY to $43.3 billion, surpassing LSEG&rsquo;s consensus estimate of&nbsp;$41.63 billion. Results were fueled by investment banking fees that grew 31% as they brought in $2.27 billion.
On the other hand, JP Morgan reported that&nbsp;net income fell 2%&nbsp;to $12.9 billion, but earnings per share rose to $4.37, up from $4.33 as there were fewer outstanding shares in the latest quarter, surpassing FactSet&rsquo;s consensus estimate of $3.99 a share.
However,&nbsp;net interest income grew 3% to $23.5 billion, surpassing both StreetAccount&rsquo;s estimate of $22.73 billion and&nbsp;FactSet&rsquo;s estimate of $22.9 billion. Consequently, JP Morgan raised its full year guidance for net interest income up from $91 billion to about&nbsp;$92.5 billion.&nbsp;
JP Morgan has et aside more money to cover credit losses, more precisely $3.1 billion, compared ot last year&rsquo;s comparable quarter when it had only set aside $1.4 billion.
During the earnings call, CFO&nbsp;Jeremy Barnum&nbsp;described the consumer is doing fine&nbsp;and is on a solid footing.&nbsp;But CEO Jamie Dimon spoke of continuously monitoring geopolitical tensions that he described as &ldquo;treacherous and getting worse.&rdquo;&nbsp;In a statement where he referred to the unspeakable human suffering, with the outcome of conflicts possibly having far-reaching effects on both short-term economic outcomes and more importantly, the course of history.&nbsp;Dimon is one of the rare CEOs who goes beyond the scope of banking to view the bigger picture of the world, often giving solicited or unsolicited advice to global leaders.
All in all, the biggest American bank continues to thrive&nbsp;in a rising rate environment.
Wells Fargo continues to evolve and generate more income through fees.&nbsp;
Wells Fargo reported third-quarter revenue dropped to $20.37&nbsp;billion, reporting a profit of $1.42 per share as net income fell to&nbsp;$5.11 billion. Net interest income also fell 11% to&nbsp;$11.69 billion, but&nbsp;the decline was offset by higher fee income.
However, the bigger picture here is that the once the country&rsquo;s #1 home mortgage lender has evolved in recent years.
Earlier this year, the Biden administration lifted a consent order that was in place since 2016&nbsp;&nbsp;following a series of scandals that included fake customer accounts.&nbsp;Last month, Wells Fargo even agreed to work with U.S. bank regulators to improve its financial crimes risk management controls that detect suspicious activity and money laundering.&nbsp;The bottom line is that despite the YoY decline of both profit and revenue, they fell less than analysts had expected.&nbsp;
By reporting better than feared results, both Wells Fargo and JP Morgan have shown that the U.S. consumers proved to be more resilient than expected, suggesting that a soft landing is more likely than a recession.&nbsp;
DISCLAIMER: This content is for informational purposes only. It is not intended as investing advice.
This article is from an unpaid external contributor. It does not represent Benzinga&#39;s reporting and has not been edited for content or accuracy.

General

JP Morgan And Wells Fargo Report Better Than Expected Q3 Results That Reflect Resilient U.S. Consumers

STOCK CLIMBS 1.5% AT HIGH POINT
<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="818" height="795" src="https://contributor-assets.benzinga.com/wp-content/uploads/2024/10/11200904/Screen-Shot-2024-10-11-at-4.12.03-PM.png" alt="" class="wp-image-2234" style="width:624px" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2024/10/11200904/Screen-Shot-2024-10-11-at-4.12.03-PM.png 818w,https://contributor-assets.benzinga.com/wp-content/uploads/2024/10/11200904/Screen-Shot-2024-10-11-at-4.12.03-PM-300x292.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2024/10/11200904/Screen-Shot-2024-10-11-at-4.12.03-PM-768x746.png 768w" sizes="(max-width: 818px) 100vw, 818px" /></figure>
MercadoLibre, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MELI#NASDAQ">MELI</a>) today experienced a Power Inflow, a significant event for those who follow where smart money goes and value order flow analytics in their trading decisions. 
Today, at 10:37 AM on OCTOBER 11th, a significant trading signal occurred for MercadoLibre, Inc. as it demonstrated a Power Inflow at a price of $2074.55. This indicator is crucial for traders who want to know directionally where institutions and so-called "smart money" moves in the market. They see the value of utilizing order flow analytics to guide their trading decisions. The Power Inflow points to a possible uptrend in MercadoLibre&#8217;s stock, marking a potential entry point for traders looking to capitalize on the expected upward movement. Traders with this signal closely watch for sustained momentum in Mercado Libre&#8217;s stock price, interpreting this event as a bullish sign.
Signal description
Order flow analytics, aka transaction or market flow analysis, separate and study both the retail and institutional volume rate of orders (flow). It involves analyzing the flow of buy and sell orders, along with size, timing, and other associated characteristics and patterns, to gain insights and make more informed trading decisions. This particular indicator is interpreted as a bullish signal by active traders.&nbsp;
The Power Inflow occurs within the first two hours of the market open. Generally, it signals the trend that helps gauge the stock&#8217;s overall direction, powered by institutional activity in the stock, for the remainder of the day.&nbsp;
By incorporating order flow analytics into their trading strategies, market participants can better interpret market conditions, identify trading opportunities, and potentially improve their trading performance. But let's not forget that while watching smart money flow can provide valuable insights, it is crucial to incorporate effective risk management strategies to protect capital and mitigate potential losses. Employing a consistent and effective risk management plan helps traders navigate the uncertainties of the market in a more controlled and calculated manner, increasing the likelihood of long-term success
If you want to stay updated on the latest options trades for MELI, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.&nbsp;
<a href="https://benzinga.com/apis?_gl=1&#x2A;1hlgn5i&#x2A;_ga&#x2A;MTY1NjE2NTYxMi4xNzE0NzQ4MTAy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDc0ODEwMi4xLjEuMTcxNDc0ODQyOC4wLjAuMA..">Market News and Data brought to you by Benzinga APIs</a> and include firms, like <a href="https://finitusa.com/en/">Finit USA</a>, responsible for parts of the data within this article. 
&#xA9; 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
After Market Close UPDATE:
The price at the time of the Power Inflow was $2074.55. The returns on the High price ($2105.33) and Close price ($2091.28) after the Power Inflow are respectively 1.5% and 0.8%. The result underlines the importance of a trading plan that includes Profit Targets and Stop Losses that reflect your risk appetite.

Signals

MELI

Tradepulse Power Inflow Alert: Mercadolibre Inc. Rises Over 30 Points After Signal

Edgewell Personal Care (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPC#NYSE">EPC</a>) underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Edgewell Personal Care, presenting an average target of $39.5, a high estimate of $41.00, and a low estimate of $37.00. A decline of 3.07% from the prior average price target is evident in the current average. 
<img src="https://www.benzinga.com/files/images/story/2024/1728680505_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The perception of Edgewell Personal Care by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$37.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$40.00</td>
<td>$41.00</td>
</tr>
<tr>
<td>Peter Grom</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$40.00</td>
<td>$42.00</td>
</tr>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$41.00</td>
<td>$40.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Edgewell Personal Care. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Edgewell Personal Care compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Edgewell Personal Care's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Edgewell Personal Care's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/EPC/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Edgewell Personal Care analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>All You Need to Know About Edgewell Personal Care</h2>
Edgewell Personal Care Co is a personal-care company. The operating segments of the company include Wet Shave, Sun and Skin Care and Feminine Care. Some of the brands offered by the company include Edge, Skintimate, Personna, Schick, Carefree, Playtex, Banana Boat and Hawaiian Tropic. It derives a majority of its revenue from the United States.
<h3>Edgewell Personal Care's Economic Impact: An Analysis</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Challenges: Edgewell Personal Care's revenue growth over 3 months faced difficulties. As of 30 June, 2024, the company experienced a decline of approximately -0.34%. This indicates a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Consumer Staples sector.
Net Margin: Edgewell Personal Care's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 7.56% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Edgewell Personal Care's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 3.13% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Edgewell Personal Care's ROA stands out, surpassing industry averages. With an impressive ROA of 1.31%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.83.
<h2>Analyst Ratings: What Are They?</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

Navigating 4 Analyst Ratings For Edgewell Personal Care

In the latest quarter, 6 analysts provided ratings for Eastman Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMN#NYSE">EMN</a>), showcasing a mix of bullish and bearish perspectives.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $106.33, along with a high estimate of $111.00 and a low estimate of $100.00. Witnessing a positive shift, the current average has risen by 4.58% from the previous average price target of $101.67.
<img src="https://www.benzinga.com/files/images/story/2024/1728680490_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Eastman Chemical. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$107.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Charles Neivert</td>
<td>Piper Sandler</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$105.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Sector Perform</td>
<td>$100.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>David Begleiter</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Hold</td>
<td>$108.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Michael Leithead</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$111.00</td>
<td>$103.00</td>
</tr>
<tr>
<td>John Roberts</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Neutral</td>
<td>$107.00</td>
<td>$102.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Eastman Chemical. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Eastman Chemical compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Eastman Chemical's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Eastman Chemical's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/EMN/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Eastman Chemical analyst ratings.</a>
<h2>All You Need to Know About Eastman Chemical</h2>
Established in 1920 to produce chemicals for Eastman Kodak, Eastman Chemical has grown into a global specialty chemical company with manufacturing sites around the world. The company generates the majority of its sales outside of the United States, with a strong presence in Asian markets. During the past several years, Eastman has sold noncore businesses, choosing to focus on higher-margin specialty product offerings.
<h3>Key Indicators: Eastman Chemical's Financial Health</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Positive Revenue Trend: Examining Eastman Chemical's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 1.68% as of 30 June, 2024, showcasing a substantial increase in top-line earnings. When compared to others in the Materials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 9.73%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 4.12%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Eastman Chemical's ROA excels beyond industry benchmarks, reaching 1.55%. This signifies efficient management of assets and strong financial health.
Debt Management: Eastman Chemical's debt-to-equity ratio is below the industry average at 0.89, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>The Significance of Analyst Ratings Explained</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Eastman Chemical Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)

In the preceding three months, 18 analysts have released ratings for UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>), presenting a wide array of perspectives from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">13</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">7</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for UnitedHealth Group, revealing an average target of $615.78, a high estimate of $680.00, and a low estimate of $591.00. Observing a 6.75% increase, the current average has risen from the previous average price target of $576.82. 
<img src="https://www.benzinga.com/files/images/story/2024/1728680474_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
The analysis of recent analyst actions sheds light on the perception of UnitedHealth Group by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Matthew Gillmor</td>
<td>Keybanc</td>
<td>Announces</td>
<td>Overweight</td>
<td>$675.00</td>
<td>-</td>
</tr>
<tr>
<td>Sarah James</td>
<td>Cantor Fitzgerald</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$591.00</td>
<td>$591.00</td>
</tr>
<tr>
<td>Sarah James</td>
<td>Cantor Fitzgerald</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$591.00</td>
<td>$591.00</td>
</tr>
<tr>
<td>Sarah James</td>
<td>Cantor Fitzgerald</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$591.00</td>
<td>$591.00</td>
</tr>
<tr>
<td>Sarah James</td>
<td>Cantor Fitzgerald</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$591.00</td>
<td>$591.00</td>
</tr>
<tr>
<td>Sarah James</td>
<td>Cantor Fitzgerald</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$591.00</td>
<td>$591.00</td>
</tr>
<tr>
<td>Sarah James</td>
<td>Cantor Fitzgerald</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$591.00</td>
<td>$591.00</td>
</tr>
<tr>
<td>Kevin Caliendo</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$680.00</td>
<td>$640.00</td>
</tr>
<tr>
<td>David Toung</td>
<td>Argus Research</td>
<td>Raises</td>
<td>Buy</td>
<td>$600.00</td>
<td>$570.00</td>
</tr>
<tr>
<td>Gary Taylor</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Buy</td>
<td>$601.00</td>
<td>$546.00</td>
</tr>
<tr>
<td>Andrew Mok</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$604.00</td>
<td>$560.00</td>
</tr>
<tr>
<td>Sarah James</td>
<td>Cantor Fitzgerald</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$591.00</td>
<td>$591.00</td>
</tr>
<tr>
<td>Stephen Baxter</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$630.00</td>
<td>$525.00</td>
</tr>
<tr>
<td>David Macdonald</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$640.00</td>
<td>$600.00</td>
</tr>
<tr>
<td>Ben Hendrix</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$615.00</td>
<td>$555.00</td>
</tr>
<tr>
<td>David Windley</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$647.00</td>
<td>$481.00</td>
</tr>
<tr>
<td>Michael Ha</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$640.00</td>
<td>$597.00</td>
</tr>
<tr>
<td>Ricky Goldwasser</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$615.00</td>
<td>$595.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to UnitedHealth Group. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of UnitedHealth Group compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for UnitedHealth Group's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
For valuable insights into UnitedHealth Group's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/UNH/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on UnitedHealth Group analyst ratings.</a>
<h2>Discovering UnitedHealth Group: A Closer Look</h2>
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to about 50 million members globally, including 1 million outside the us as June 2024. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
<h3>UnitedHealth Group's Financial Performance</h3>
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Revenue Growth: UnitedHealth Group's remarkable performance in 3 months is evident. As of 30 June, 2024, the company achieved an impressive revenue growth rate of 6.61%. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Health Care sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: UnitedHealth Group's net margin excels beyond industry benchmarks, reaching 4.31%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): UnitedHealth Group's ROE excels beyond industry benchmarks, reaching 4.79%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 1.48%, the company showcases effective utilization of assets.
Debt Management: With a high debt-to-equity ratio of 0.84, UnitedHealth Group faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Peeling Back The Layers: Exploring UnitedHealth Group Through Analyst Insights

Analysts' ratings for Encompass Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EHC#NYSE">EHC</a>) over the last quarter vary from bullish to bearish, as provided by 8 analysts.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Encompass Health, revealing an average target of $106.0, a high estimate of $115.00, and a low estimate of $100.00. Surpassing the previous average price target of $100.57, the current average has increased by 5.4%.
<img src="https://www.benzinga.com/files/images/story/2024/1728680459_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
A comprehensive examination of how financial experts perceive Encompass Health is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Matthew Gillmor</td>
<td>Keybanc</td>
<td>Announces</td>
<td>Overweight</td>
<td>$115.00</td>
<td>-</td>
</tr>
<tr>
<td>Ben Hendrix</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$105.00</td>
<td>$95.00</td>
</tr>
<tr>
<td>Andrew Mok</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$110.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>David Macdonald</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$104.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Andrew Mok</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$100.00</td>
<td>$96.00</td>
</tr>
<tr>
<td>Scott Fidel</td>
<td>Stephens &amp; Co.</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$105.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Andrew Mok</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$109.00</td>
<td>$113.00</td>
</tr>
<tr>
<td>David Macdonald</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$100.00</td>
<td>$95.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Encompass Health. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Encompass Health compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Encompass Health's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
To gain a panoramic view of Encompass Health's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/EHC/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Encompass Health analyst ratings.</a>
<h2>About Encompass Health</h2>
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.
<h3>Encompass Health: Financial Performance Dissected</h3>
Market Capitalization Analysis: The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.
Revenue Growth: Encompass Health's remarkable performance in 3 months is evident. As of 30 June, 2024, the company achieved an impressive revenue growth rate of 9.61%. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Health Care sector.
Net Margin: Encompass Health's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 8.71%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Encompass Health's ROE excels beyond industry benchmarks, reaching 6.33%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Encompass Health's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.8% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 1.6.
<h2>Analyst Ratings: What Are They?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Decoding 8 Analyst Evaluations For Encompass Health

Ratings for eBay (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EBAY#NASDAQ">EBAY</a>) were provided by 19 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">11</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $60.84, a high estimate of $70.00, and a low estimate of $46.00. Surpassing the previous average price target of $55.94, the current average has increased by 8.76%.
<img src="https://www.benzinga.com/files/images/story/2024/1728680450_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
A comprehensive examination of how financial experts perceive eBay is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Colin Sebastian</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$70.00</td>
<td>$62.00</td>
</tr>
<tr>
<td>Ken Gawrelski</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$63.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Deepak Mathivanan</td>
<td>Cantor Fitzgerald</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$62.00</td>
<td>$62.00</td>
</tr>
<tr>
<td>Justin Post</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Neutral</td>
<td>$65.00</td>
<td>$57.00</td>
</tr>
<tr>
<td>Deepak Mathivanan</td>
<td>Cantor Fitzgerald</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$62.00</td>
<td>$62.00</td>
</tr>
<tr>
<td>Deepak Mathivanan</td>
<td>Cantor Fitzgerald</td>
<td>Announces</td>
<td>Neutral</td>
<td>$62.00</td>
<td>-</td>
</tr>
<tr>
<td>Youssef Squali</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Hold</td>
<td>$58.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Eric Sheridan</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Sell</td>
<td>$46.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Shyam Patil</td>
<td>Susquehanna</td>
<td>Raises</td>
<td>Neutral</td>
<td>$60.00</td>
<td>$52.00</td>
</tr>
<tr>
<td>Ygal Arounian</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$65.00</td>
<td>$64.00</td>
</tr>
<tr>
<td>Lee Horowitz</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Buy</td>
<td>$64.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Daniel Kurnos</td>
<td>Benchmark</td>
<td>Raises</td>
<td>Buy</td>
<td>$65.00</td>
<td>$58.00</td>
</tr>
<tr>
<td>Mark Mahaney</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>In-Line</td>
<td>$53.00</td>
<td>$47.00</td>
</tr>
<tr>
<td>Brian Pitz</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$59.00</td>
<td>$53.00</td>
</tr>
<tr>
<td>Thomas Champion</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$64.00</td>
<td>$58.00</td>
</tr>
<tr>
<td>Ken Gawrelski</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$55.00</td>
<td>$57.00</td>
</tr>
<tr>
<td>Colin Sebastian</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$62.00</td>
<td>$58.00</td>
</tr>
<tr>
<td>Justin Post</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Neutral</td>
<td>$57.00</td>
<td>$53.00</td>
</tr>
<tr>
<td>Nathan Feather</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$64.00</td>
<td>$61.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to eBay. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of eBay compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for eBay's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
For valuable insights into eBay's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/EBAY/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on eBay analyst ratings.</a>
<h2>Discovering eBay: A Closer Look</h2>
EBay operates one of the largest e-commerce marketplaces in the world, with $73 billion in 2023 gross merchandise volume, or GMV, rendering the firm a top 10 global e-commerce company. The company generates revenue from listing fees, advertising, revenue-sharing arrangements with service providers, and managed payments, with its platform connecting more than 130 million buyers and roughly 20 million sellers across almost 190 global markets at the end of 2023. EBay generates just north of 50% of its GMV in international markets, with a large presence in the UK, Germany, and Australia.
<h3>Key Indicators: eBay's Financial Health</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: eBay displayed positive results in 3 months. As of 30 June, 2024, the company achieved a solid revenue growth rate of approximately 1.26%. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Consumer Discretionary sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 8.71%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): eBay's ROE excels beyond industry benchmarks, reaching 3.8%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 1.07%, the company showcases effective utilization of assets.
Debt Management: eBay's debt-to-equity ratio is below the industry average. With a ratio of 1.48, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>Analyst Ratings: Simplified</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

EBAY

Key Takeaways From eBay Analyst Ratings

Aldebaran Resources Inc (TSE:ALDE) has released an update. Aldebaran Resources Inc. announced significant expansions in mineralization at its Altar...

Aldebaran Resources Strikes Broad Mineralization

Aldebaran Resources Inc (TSE:ALDE) has released an update. Aldebaran Resources Inc. has announced encouraging results from its recent drilling camp...

Aldebaran Reports Promising Drilling Results at Altar Project

Aldebaran Resources Inc (TSE:ALDE) has released an update. Aldebaran Resources Inc. has announced promising results from its latest drilling campai...

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Comments

Aldebaran Resources

News

Latest news for Aldebaran Resources (OTC:ADBRF) Stock